Theme: To create global awareness and to share novel approaches on treating Liver and Pancreatic Diseases

Hepatology 2017

Hepatology 2017

Conference Series LLC will be pleased to invite you to the 4th International Conference on Hepatology  to be held in beautiful city, Dubai, UAE during May 04-06, 2017. The conference highlights the theme “To create global awareness and to share novel approaches on treating Liver and Pancreatic Diseases”.

The conference proceedings include symposiums and workshops, keynote speeches, plenary talks, poster sessions and panel discussion on latest research developments in the field of Hepatology.

OMICS International organizes 300+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. - See more at: http://pancreas.conferenceseries.com/#sthash.Z11s31NP.dpuf

Conference Series LLC organizes 600+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Conference Highlights

Hepatology

Diagnosing Liver Diseases

Liver Diseases

Viral and Non-viral Hepatitis

Hepatocellular Carcinoma

Pancreatic Cancer

Liver Transplantation and Surgery

Pancreatic and Biliary Duct Diseases

Bile formation and Related Diseases

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

 

Track 1: Hepatology

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas function as well as management of their disorders. The study of these organ deals with the understanding of clinical syndrome of non-cirrhotic portal hypertension and Congenital Hepatic Fibrosis; study the biological processes underlying the development of hepatic regeneration and study aspects of viral hepatitis that allow insight into disease mechanisms.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 10-12, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA

Track 2: Diagnosing Liver Diseases

Diagnosis for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status. Ultrasound-based transient elastography is the advanced technology more commonly used for the assessment of chronic liver diseases. It is also used to predict complications in patients with Liver cirrhosis.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 10-12, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA

Track 3: Liver Diseases

Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 10-12, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA

Track 4: Viral and Non-viral Hepatitis

Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis.  

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; Latin and Ibero American Congress of Paediatric Gastroenterology, Hepatology and Nutrition, November 18-21, 2015, Lima, Peru; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 5: Hepatocellular Carcinoma           

Hepatocellular carcinoma accounts for most liver cancers. This type of liver cancer occurs more often in men than women and is usually seen in people age 50 or older. It is commonly associated with cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of hepatocellular carcinoma. Other risk factors can include a history of alcohol abuse.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA.

Track 6: Pancreatic Cancer

Pancreatic cancer is the fourth leading cause of cancer death. Most pancreatic cancers are exocrine tumors. These tumors do not secrete hormones and do not cause signs or symptoms. Pancreatic cancer often has a poor prognosis, even when diagnosed early. Pancreatic cancer typically spreads rapidly and is seldom detected in its early stages, which is a major reason why it's a leading cause of cancer death.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2nd International Hepatology Conference, May 09-11, 2016, USA; 6th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

 

Track 7: Transplantation and Surgery

Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, memory and thinking problems.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; National Liver Conference, September 18, 2015, Fort Worth, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore.

Track 8: Pancreatic and Biliary Duct Diseases

The pancreas and biliary tract is crucial secondary organ for the human digestive system as when they don't work properly, it affects the entire body. Pancreatic and biliary tract problems can cause severe abnormalities such as stomach pain, bloating, nausea and vomiting. Anyone with such symptoms, especially when they are severe and long lasting, should see a doctor immediately as to receive perfect care and prevention.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2nd International Hepatology Conference, May 09-11, 2016, USA; 6th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 9: Bile formation and Related Diseases

Bile is a fluid that is made and released by the liver and stored in the gallbladder. Bile helps with digestion. It breaks down fats into fatty acids, which can be taken into the body by the digestive tract. Bile contains mostly cholesterol, bile acids and bilirubin. It also contains water, body salts, copper and other metals.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2nd International Hepatology Conference, May 09-11, 2016, USA; 6th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

 

Hepatology 2016

2nd International Conference on Hepatology (Hepatology-2016) organised by Conference Series LLC took place at Double Tree by Hilton Hotel Chicago - North Shore, Chicago, USA during May 09-11, 2016. The conference highlighted the theme, “To discuss and share the latest updates and cutting-edge technologies in the field of Hepatology”. It is an annual meeting for the study of Liver and Pancreatic diseases.

We successfully hosted Hepatology 2016 conference with the support and contribution of the organizing committee members. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations. Active participation and generous response were received from the Organizing Committee Members and Editorial Board Members of OMICS International Journals. Professors, Researchers, and Students from diverse groups made this conference as one of the most successful and productive event in 2016 from Conference Series LLC.

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. David Van Thiel, Rush University Medical Center, USA followed by Dr. Trent W Nichols, AMRI, USA. Our special thanks to Dr. Eve Isabelle Pecheur, Cancer Research Center of Lyon, France and Dr. Sumathi Ramachandran, Centers for Disease Control and Prevention, USA, the Honorable Moderators for the conference who contributed a major part for the success of this event.

The highlights of the meeting were the enlightening keynote lectures from:

  • Dr. David Van Thiel, Rush University Medical Center, USA on the topic, “Endocan a valuable biomarker for Hepatocellular Carcinoma (HCC)”.
  • Dr. Trent W Nichols, AMRI, USA on the topic, “Wnt signaling in hepatocellular carcinoma, an emerging epidemic: Gene up regulation of Wnt 5a pathways with toll receptor 4 with moderated magnetic fields on human stem cells and mice and high dose vitamin D3 prevention”.
  • Mark A Feitelson, Temple University, USA on the topic, “Symbiotic bacteria provide chemoprevention against hepatitis B virus mediated hepatocellular carcinoma in hepatitis B x transgenic mice”.
  • Eve-Isabelle Pecheur, Cancer Research Center of Lyon, France on the topic, “Hepatitis C virus infection: A subtle but toxic combination of lipids, proteins and sugars”.
  • Anil Kaul, Oklahoma State University, USA on the topic, “Microflora and TLRs in HCV-related cirrhosis and hepatocellular carcinoma”.

The conference proceedings were carried out through various scientific sessions and plenary lectures:

  • Title: Chronic Hepatitis Delta Virus (HDV) infection: What do we need to know? by Raffaella Romeo, University of Milan, Italy.
  • Title: Incidence of the hepatitis C in prison in France: Results of a study by POCT presented by André-Jean Remy, Perpignan Hospital, France.
  • Title: Hepatitis C Virus (HCV) genotype 1b as a risk factor for hepatocellular carcinoma development in chronic HCV positive patients in Southern Italy presented by Arnolfo Petruzziello, IRCCS, Italy.
  • Title: Connexins and pannexins as novel drug targets in the treatment of acute and chronic liver disease lectured by Mathieu Vinken, Free University Brussels, Belgium.
  • Title: Hepatitis B and C care in the opiate substitution setting-An integrated nursing model of care delivered by Vince Fragomeli, Nepean Hospital, Australia.
  • Title: Using NUCs in prevention of mother-to-child transmission of HBV: To treat or not to treat? given by Yuming Wang, Third Military Medical University, China.
  • Title: Hepatitis outbreaks and surveillance: Advanced molecular detection and beyond presented by Sumathi Ramachandran, Centers for Disease Control and Prevention, USA.
  • Title: The regulation and functional roles of the HCV NS5A-stabilizing factor, Y-Box binding protein 1, in HCV life cycle shared by Wei-Ting Wang, National Chiao-Tung University, Taiwan.
  • Title: Hepatitis B virus in Cote d Ivoire (West Africa) lectured by Alphonsine Kouassi-M Bengue, University Felix Houphouet Boigny, Cote d Ivoire.
  • Title: Epidemiological characteristics of hepatocellular carcinoma in Egypt: A retrospective analysis of 1313 cases shared by Mohammed Omar Khalifa, Ain Shams University School of Medicine, Egypt.
  • Title: Anticancer activity of Aloe vera and Calligonum comosum extracts separately on hepatocellular carcinoma cells given by Mahmoud M Zakaria Ibrahim, Mansoura University, Egypt.
  • Title: HCV diagnosis in China by Bingshui Xiu, Beijing Institute of Basic Medical Sciences, China.

Conference Series LLC has taken the privilege of felicitating Hepatology 2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. Conference Series LLC, congratulate the Best Poster awardee Md Kamrul Hasan Chowdhury, University of New South Wales, Australia.

We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS International Journal, Journal of Liver as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of OMICS International Journals, Participants, Attendees and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, Conference Series LLC would like to announce the commencement of the “3rd World Congress on Hepatitis and Liver Diseases” during October 10-12, 2016 in Dubai, UAE and “4th International Conference on Hepatology” during May 04-06, 2017 in Dubai, UAE.

Let us meet again @ Hepatitis 2016 & Hepatology 2017


Past Reports  Proceedings  Gallery  

Hepatitis 2015

OMICS International takes a great pride in announcing the commencement of "World Congress on Hepatitis” during July 20-22, 2015 at Hyatt Regency Orlando International Airport, Florida, USA. The conference highlights the theme “Raising global awareness on hepatitis and fighting the stigma surrounding the disease”. It is the annual meeting for the study of Hepatitis.

With the support and contribution of the organizing committee members, we successfully hosted an event at the conference venue. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals, Professors, Researchers, Experts and Students from diverse groups who made this conference as one of the most successful and productive event in 2015 from OMICS International. The conference was marked with the attendance of young researchers, business delegates and students who have driven this event into the path of success.  

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. Mark A Feitelson, Associate Director, Temple University, USA. The proceedings went through interactive sessions and panel discussions headed by Dr. Trent W Nichols, AMRI, USA, an honorable Moderator for the conference, who contributed a major part for the success of this event. The event offers a best platform with its well organized scientific program to the audience on the topics Hepatitis Care and Cure, Diagnosis & Liver Pathology/ Case Studies, Assessment of Liver Diseases, Liver  cancer and Hepatocellular carcinoma, Advanced Management of Liver diseases, Clinical Liver Transplantation and Liver Surgery, Advancement in new drug discovery for treatment of hepatitis, Advance Technologies for the treatment of hepatitis and Liver diseases, Current research in Hepatology.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of hepatitis, carried out through various scientific-sessions and plenary lectures:

  • Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? -Dr. Mark A Feitelson, Temple University, USA
  • The Growing Epidemic in HCC from Hepatitis/NASH Cirrhosis in American Veterans-Dr. Trent W Nichols, AMRI, USA
  • Lower GI Bleeding in Patients with cirrhosis- Dr. Maxwell M Chait, Columbia University, USA
  • Impacts of platelets on the prognosis of patients with hepatocellular carcinoma– Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan

Also, the conference proceeding was encouraged through the wonderful symposiums by Dr. Andre Jean Remy, Perpignan Hospital, France, on the title ” New tools of screening viral hepatitis in real life: The French model of care and by Dr. Ehab Abd-El-Atty, Menoufia University, Egypt, on the title “HCC risk factors synergism in Egypt and how to prevent?”

A workshop session was done on “The Cirrhosis Micro-environment and Hepato-carcinogenesis” by Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan.

OMICS International has taken the privilege of felicitating Hepatitis-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS International, on behalf of the conference exhibitor congratulate the Best Poster awardee for her outstanding performance in the field of Hepatocellular carcinoma and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. 

We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Journal of Liver and Journal of Liver Disease and Transplantation as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of OMICS Journals, Participants, Attendees, Sponsors, Exhibitors, and Media partners for their gracious presence and generous support, without which the conference would not have been possible. With the unique feedback from the conference, OMICS International would like to announce the commencement of the "2nd International Conference on Hepatology” May 9-11, 2016 in Chicago, USA and “3rd World Congress on Hepatitis and Liver Diseases" October 17-19, 2016 in Dubai, UAE.

 

Let us meet again @ 2016 Conferences


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date April 27-29, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Testimonials

Conferenceseries Destinations